Chemoinformaics analysis of Trans-Linalol-Oxide (Furanoid)
| Molecular Weight | 170.252 | nRot | 2 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 6 |
| Exact Molecular Weight | 170.131 | nRing | 1 |
| Solubility: LogS | -0.777 | nHRing | 1 |
| Solubility: LogP | 1.757 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 30.3063 |
| nHD | 1 | BPOL | 19.7937 |
| QED | 0.641 |
| Synth | 4.037 |
| Natural Product Likeliness | 3.614 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.253 |
| MDCK | 0.0000267 |
| BBB | 0.966 |
| PPB | 0.609248 |
| VDSS | 1.437 |
| FU | 0.420072 |
| CYP1A2-inh | 0.03 |
| CYP1A2-sub | 0.601 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.885 |
| CYP2c9-inh | 0.03 |
| CYP2c9-sub | 0.224 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.385 |
| CYP3a4-inh | 0.095 |
| CYP3a4-sub | 0.347 |
| CL | 6.418 |
| T12 | 0.625 |
| hERG | 0.012 |
| Ames | 0.02 |
| ROA | 0.042 |
| SkinSen | 0.175 |
| Carcinogencity | 0.131 |
| EI | 0.906 |
| Respiratory | 0.041 |
| NR-Aromatase | 0.019 |
| Antiviral | No |
| Prediction | 0.942706 |